Entropic contribution to the linking coefficient in fragment based drug design: A case study

Journal of Medicinal Chemistry

Volumn 53, Issue 10, 2010, Pages 4285-4289

  Borsi, Valentina ^a   Calderone, Vito ^a   Fragai, Marco ^a   Luchinat, Claudio ^a   Sarti, Niko ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENESULFONAMIDE DERIVATIVE;

ARTICLE; CASE STUDY; CORRELATION COEFFICIENT; DRUG DESIGN; ENTROPY; HETERONUCLEAR SINGLE QUANTUM COHERENCE; ISOTHERMAL TITRATION CALORIMETRY; PROTEIN EXPRESSION; THERMODYNAMICS; X RAY CRYSTALLOGRAPHY;

CALORIMETRY; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; ENTROPY; HYDROXAMIC ACIDS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MATRIX METALLOPROTEINASE 12; MODELS, MOLECULAR; PROTEIN BINDING; SULFONAMIDES;

EID: 77952713014     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm901723z     Document Type: Article

References (38)

1. Shuker, S. B.; Hajduk, P. J.; Meadows, R. P.; Fesik, S. W. Discovering high-affinity ligands for proteins: SAR by NMR Science 1996, 274, 1531-1534
2. Erlanson, D. A.; Braisted, A. C.; Raphael, D. R.; Randal, M.; Stroud, R. M.; Gordon, E. M.; Wells, J. A. Site-directed ligand discovery Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 9367-9372
3. Bajorath, F. Integration of virtual and high-throughput screening Nat. Rev. Drug Discovery 2002, 1, 882-894
4. Bleicher, K. H.; Bohm, H. J.; Muller, K.; Alanine, A. I. Hit and lead generation: beyond high-throughput screening Nat. Rev. Drug Discovery 2003, 2, 369-378
5. Blundell, T. L.; Jhoti, H.; Abell, C. High-throughput crystallography for lead discovery in drug design Nat. Rev. Drug Discovery 2002, 1, 45-54
6. Congreve, M.; Carr, R.; Murray, C.; Jhoti, H. A rule of three for fragment-based lead discovery? Drug Discovery Today 2003, 8, 876-877
7. II matrix metalloproteinase 12 Angew. Chem., Int. Ed. 2004, 43, 2254-2256
8. Bertini, I.; Fragai, M.; Luchinat, C.; Talluri, E. Water-based ligand screening for paramagnetic metalloproteins Angew. Chem., Int. Ed. 2008, 47, 4533-4537
9. Pellecchia, M.; Bertini, I.; Cowburn, D.; Dalvit, C.; Giralt, E.; Jahnke, W.; James, T. L.; Homans, S. W.; Kessler, H.; Luchinat, C.; Meyer, B.; Oschkinat, H.; Peng, J.; Schwalbe, H.; Siegal, G. Perspectives on NMR in drug discovery: a technique comes of age Nat. Rev. Drug Discovery 2008, 7, 738-745
10. Hajduk, P. J.; Greer, J. A decade of fragment-based drug design: strategic advances and lessons learned Nat. Rev. Drug Discovery 2007, 6, 211-219
11. Chen, Y.; Shoichet, B. K. Molecular docking and ligand specificity in fragment-based inhibitor discovery Nat. Chem. Biol. 2009, 5, 358-364
12. Ciulli, A.; Williams, G.; Smith, A. G.; Blundell, T. L.; Abell, C. Probing hot spots at protein-ligand binding sites: a fragment-based approach using biophysical methods J. Med. Chem. 2006, 49, 4992-5000
13. Pellecchia, M. Fragment-based drug discovery takes a virtual turn Nat. Chem. Biol. 2009, 5, 274-275
14. Hajduk, P. J.; Sheppard, G.; Nettesheim, D. G.; Olejniczak, E. T.; Shuker, S. B.; Meadows, R. P.; Steinman, D. H.; Carrera, G. M.; Marcotte, P. A.; Severin, J.; Walter, K.; Smith, H.; Gubbins, E.; Simmer, R.; Holzman, T. F.; Morgan, D. W.; Davidsen, S. K.; Summers, J. B.; Fesik, S. W. Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR J. Am. Chem. Soc. 1997, 119, 5818-5827
15. Olejniczak, E. T.; Hajduk, P. J.; Marcotte, P. A.; Nettesheim, D. G.; Meadows, R. P.; Edalji, R.; Holzman, T. F.; Fesik, S. W. Stromelysin inhibitors designed from weakly bound fragments: effects of linking and cooperativity J. Am. Chem. Soc. 1997, 119, 5828-5832
16. Page, M. I.; Jencks, W. P. Entropic contributions to rate accelerations in enzymic and intramolecular reactions and the chelate effect Proc. Natl. Acad. Sci. U.S.A. 1971, 68, 1678-1683
17. Jencks, W. P. On the attribution and additivity of binding energies Proc. Natl. Acad. Sci. U.S.A. 1981, 78, 4046-4050
18. Murray, C. W.; Verdonk, M. L. The consequences of translational and rotational entropy lost by small molecules on binding to proteins J. Comput.-Aided Mol. Des. 2002, 16, 741-753
19. Pellecchia, M. Solution nuclear magnetic resonance spectroscopy techniques for probing intermolecular interactions Chem. Biol. 2005, 12, 961-971
20. Congreve, M. S.; Davis, D. J.; Devine, L.; Granata, C.; OReilly, M.; Wyatt, P. G.; Jhoti, H. Detection of ligands from a dynamic combinatorial library by X-ray crystallography Angew. Chem., Int. Ed. 2003, 42, 4479-4482
21. Babaoglu, K.; Shoichet, B. K. Deconstructing fragment-based inhibitor discovery Nat. Chem. Biol. 2006, 2, 720-723
22. MacPherson, L. J.; Bayburt, E. K.; Capparelli, M. P.; Carroll, B. J.; Goldstein, R.; Justice, M. R.; Zhu, L.; Hu, S.; Melton, R. A.; Fryer, L.; Goldberg, R. L.; Doughty, J. R.; Spirito, S.; Blancuzzi, V.; Wilson, D.; OByrne, E. M.; Ganu, V.; Parker, D. T. Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits J. Med. Chem. 1997, 40, 2525-2532
23. Bertini, I.; Fragai, M.; Luchinat, C. Intra- and interdomain flexibility in matrix metalloproteinases: functional aspects and drug design Curr. Pharm. Des. 2009, 15, 3592-3605
24. Stockmann, H.; Bronowska, A.; Syme, N. R.; Thompson, G. S.; Kalverda, A. P.; Warriner, S. L.; Homans, S. W. Residual ligand entropy in the binding of p-substituted benzenesulfonamide ligands to bovine carbonic anhydrase II J. Am. Chem. Soc. 2008, 130, 12420-12426
25. Whitesides, G. M.; Krishnamurthy, V. M. Designing ligands to bind proteins Q. Rev. Biophys. 2005, 38, 385-395
26. Srivastava, D. K.; Jude, K. M.; Banerjee, A. L.; Haldar, M.; Manokaran, S.; Kooren, J.; Mallik, S.; Christianson, D. W. Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II J. Am. Chem. Soc. 2007, 129, 5528-5537
27. Matulis, D.; Todd, M. In Thermodynamics/Structure Correlations of Sulfonamide Inhibitor Binding to Carbonic Anhydrase in Biocalorimetry 2; Ladbury, J.; Doyle, M., Eds.; Wiley & Sons: New York, 2004.
28. Bertini, I.; Calderone, V.; Fragai, M.; Luchinat, C.; Mangani, S.; Terni, B. Crystal structure of the catalytic domain of human matrix metyalloproteinase 10 J. Mol. Biol. 2004, 336, 707-716
29. Bertini, I.; Calderone, V.; Cosenza, M.; Fragai, M.; Lee, Y.-M.; Luchinat, C.; Mangani, S.; Terni, B.; Turano, P. Conformational variability of MMPs: beyond a single 3D structure Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 5334-5339
30. Bertini, I.; Calderone, V.; Fragai, M.; Giachetti, A.; Loconte, M.; Luchinat, C.; Maletta, M.; Nativi, C.; Yeo, K. J. Exploring the subtleties of drug-receptor interactions: the case of matrix metalloproteinases J. Am. Chem. Soc. 2007, 129, 2466-2475
31. Dunitz, J. D. The entropic cost of bound water in crystals and biomolecules Science 1994, 264, 670
32. Whitty, A. Cooperativity and biological complexity Nat. Chem. Biol. 2008, 4, 435-439
33. Cha, J.; Auld, D. S. Site-directed mutagenesis of the active site glutamate in human matrilysin: investigation of its role in catalysis Biochemistry 1997, 36, 16019-16024
34. Parker, M. H.; Lunney, E. A.; Ortwine, D. F.; Pavlovsky, A. G.; Humblet, C.; Brouillette, C. G. Analysis of the binding of hydroxamic acid and carboxylic acid inhibitors to the stromelysin-1 (matrix metalloproteinase-3) catalytic domain by isothermal titration calorimetry Biochemistry 1999, 38, 13592-13601
35. Holman, C. M.; Kan, C. C.; Gehring, M. R.; Van Wart, H. E. Role of His-224 in the anomalous pH dependence of human stromelysin-1 Biochemistry 1999, 38, 677-681
36. Ciulli, A.; Abell, C. Fragment-based approaches to enzyme inhibition Curr. Opin. Biotechnol. 2007, 18, 489-496
37. Chung, S.; Parker, J. B.; Bianchet, M.; Amzel, L. M.; Stivers, J. T. Impact of linker strain and flexibility in the design of a fragment-based inhibitor Nat. Chem. Biol. 2009, 5, 407-413
38. Hung, A. W.; Silvestre, H. L.; Wen, S.; Ciulli, A.; Blundell, T. L.; Abell, C. Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase Angew. Chem., Int. Ed. 2009, 8452-8456